NL-OMON41389已完成4 期
Vitamin K antagonist (VKA) therapy versus New Oral Anticoagulants (NOACs) therapy in patients with currently well controlled VKA therapy for non-valvular atrial fibrillation: a pilot study - GAIn
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 240
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Men or women aged >18 years who are currentlly treated with VKA for non-valvular AF, managed by participating Thrombosis Service;-A minimum duration of 6 months of VKA treatment prior to the screening visit.;- An ITTR> 60% over the 4 months of VKA treatment before selection by the Thromobosis Service;D4b. In het Nederlands
排除标准
- •-thrombo-embolic event or major bleeding ever while on VKA;-Indication for anticoagulation other then AF;-contra-indication to receive NOACs, i.e. reduced renal clearance defined as <30ml/min (Cockroft-Gault formula)
研究者
相似试验
尚未招募
不适用
Goede Antistolling In Noord Nederland: Vergelijking tussen vitamine K antagonisten (VKA) en nieuwe orale anticoagulantia in patienten met boezemfibrilleren die het nu goed doen op VKAantagonisten en Nieuwe Orale anticoagulantia in patienten die momenteel goed ingesteld zijn op een vitamine K antagonist.on-valvular atrial fibrillation Vitamin K antagonists New Oral AnticoagulantsNL-OMON28322niversity Medical Centre Groningen240
进行中（未招募）
1 期
Research on anticoagulant treatment in atrial fibrillatioEUCTR2013-004805-14-NLniversity Medical Center Groningen241
已完成
不适用
Prospective study of non-vitamin K antagonist oral anticoagulants (NOACs) management in Japanese patients with deep vein thrombosis and pulmonary embolism (DVT/PE)Venous thrombosisJPRN-UMIN000023747Department of Cardiology and Nephrology, Mie University Graduate School of Medicine1,000
尚未招募
不适用
efficacy and safety of non vitamin K anticoagulants compared to vitamin K anticoagulants in treatment of atrial fibrillation patientsCTRI/2022/05/042669srm college of pharmacy
招募中
不适用
The efficacy and Safety of non-vItamiN K antaGonist oraL anticoagulants for intermEdiate stroke risk in patients with Atrial Fibrillation (SINGLE AF study)Diseases of the circulatory systemKCT0005141Yonsei University Health System, Severance Hospital1,800